The endothelial-mesenchymal transition (EndMT) and tissue regeneration

Current Stem Cell Research and Therapy

Volumn 9, Issue 3, 2014, Pages 196-204

  Yu, Wenjing ^a,b   Liu, Zhen ^c   An, Shu ^a,b   Zhao, Jinyi ^a,b   Xiao, Lan ^a,b   Gou, Yongchao ^a,b   Lin, Yunfeng ^a,b   Wang, Jun ^a,b  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c AFFILIATED HOSPITAL OF NORTH SICHUAN MEDICAL COLLEGE   (China)

Author keywords

EndMT transformed cells; Endothelial cells; Endothelial mesenchymal transition (EndMT); Mesenchymal stem cells (MSCs); Tissue regeneration; Transforming growth factor (TGF )

Indexed keywords

ANIMALS; CELL DIFFERENTIATION; ENDOTHELIUM; HUMANS; MESODERM; REGENERATION; TISSUE ENGINEERING;

EID: 84899646430     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X09666140213154144     Document Type: Article

References (80)

1. Markwald RR, Fitzharris TP, Smith WN. Sturctural analysis of endocardial cytodifferentiation. Dev Biol 1975; 42(1): 160-80.
2. Noseda M, McLean G, Niessen K, et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res 2004; 94(7): 910-7.
3. Medici D, Kalluri R. Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype. Semin Cancer Biol 2012; 22(5-6): 379-84.
4. Arciniegas E, Neves YC, Carrillo LM. Potential role for insulin-like growth factor II and vitronectin in the endothelial-mesenchymal transition process. Differentiation 2006; 74(6): 277-92.
5. Potenta S, Zeisberg E, Kalluri R. The role of endothelial-to-mesenchymal transition in cancer progression. Br J Cancer 2008; 99(9): 1375-9.
6. Medici D, Shore EM, Lounev VY, Kaplan FS, Kalluri R, Olsen BR. Conversion of vascular endothelial cells into multipotent stem-like cells. Nat Med 2010; 16(12): 1400-6.
7. Nataraj D, Ernst A, Kalluri R. Idiopathic pulmonary fibrosis is associated with endothelial to mesenchymal transition. Am J Respir Cell Mol Biol 2010; 43(2): 129-30.
8. Kim M, Choi SH, Jin YB, et al. The effect of oxidized LDL on radiation-induced endothelial-to-mesenchymal transition. Int J Radiat Biol 2013.
9. Medici D, Olsen BR. The role of endothelial-mesenchymal transition in heterotopic ossification. J Bone Miner Res. 2012; 27(8): 1619-22.
10. Peng L, Ye L, Zhou XD. Mesenchymal stem cells and tooth engineering. Int J Oral Sci. 2009; 1(1): 6-12.
11. Kokudo T, Suzuki Y, Yoshimatsu Y, Yamazaki T, Watabe T, Miyazono K. Snail is required for TGFbeta-induced endothelial mesenchymal transition ofembryonic stem cell-derived endothelial cells. J Cell Sci. 2008; 121(Pt 20): 3317-24.
12. Arciniegas E, Frid MG, Douglas IS, Stenmark KR. Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol 2007; 293(1): L1-8.
13. Piera-Velazquez S, Li Z, Jimenez SA. Role of endothelial mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179(3): 1074-80.
14. Lin F, Wang N, Zhang TC. The role of endothelial-mesenchymal transition in development and pathological process. IUBMB Life 2012; 64(9): 717-23.
15. Sato Y, Nakanuma Y. Role of endothelial-mesenchymal transition in idiopathic portal hypertension. Histol Histopathol 2013; 28(2): 145-54.
16. Niessen K, Karsan A. Notch signaling in the developing cardiovascular system. Am J Physiol Cell Physiol 2007; 293(1): C1-11.
17. Lagendijk AK, Goumans MJ, Burkhard SB, Bakkers J, MicroRNA-23 restricts cardiac valve formation by inhibiting Has2 and extracellular hyaluronic acid production. Circ Res 2011; 109(6): 649-57.
18. Lagendijk AK, Szabo A, Merks RM, Bakkers J. Hyaluronan: A critical regulator of endothelial-to-mesenchymal transition during cardiac valve formation.LID-S1050-1738(12)00401-X [pii]LID-10.1016/j.tcm.2012.10.002 [doi]. Trends Cardiovasc Med. 2013.
19. Wynn TA. Cellular and molecular mechanisms of fibrosis. J Pathol 2008; 214(2): 199-210.
20. Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13(8): 952-61.
21. Zeisberg EM, Potenta SE, Sugimoto H, Zeisberg M, Kalluri R. Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition. J Am Soc Nephrol 2008; 19(12): 2282-7.
22. Piera-Velazquez S, Jimenez SA. Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis Tissue Repair 2012; 5 Suppl 1: S7.
23. Hashimoto N, Phan SH, Imaizumi K, et al. Endothelial mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 2010; 43(2): 161-72.
24. Nakanuma Y, Sato Y, Kiktao A. Pathology and pathogenesis of portal venopathy in idiopathic portal hypertension:Hints from systemic sclerosis. Hepatol Res 2009; 39(10): 1023-31.
25. Kitao A, Sato Y, Sawada-Kitamura S, et al. Endothelial to mesenchymal transition via transforming growth factor-beta1/Smad activation is associated with portal venous stenosis in idiopathic portal hypertension. Am J Pathol 2009; 175(2): 616-26.
26. Rieder F, Kessler SP, West GA, et al. Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis. Am J Pathol 2011; 179(5): 2660-73.
27. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science. Curr Opin Gastroenterol 2008; 24(4): 462-8.
28. Rieder F, Fiocchi C. Intestinal fibrosis in inflammatory bowel disease-Current knowledge and future perspectives. J Crohns Colitis 2008; 2(4): 279-90.
29. Garcia J, Sandi MJ, Cordelier P, et al. Tie1 deficiency induces endothelial-mesenchymal transition. LID-10.1038/embor.2012.29 [doi]. EMBO Rep. 2012.
30. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97(6): 512-23.
31. Partridge CR, Hawker JR Jr, Forough R. Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J Cell Biochem; 2000. 78(3): 487-99.
32. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006; 6(5): 392-401.
33. Bierie B, Moses HL. TGF-beta and cancer. Cytokine Growth Factor Rev 2006; 17(1-2): 29-40.
34. Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source forcarcinoma associated fibroblasts. Cancer Res 2007; 67(21): 10123-8.
35. Akhurst RJ. TGF beta signaling in health and disease. Nat Genet 2004; 36(8): 790-2.
36. Selek L, Dhobb M, van der Sanden B, Berger F, Wion D. Existence of tumor-derived endothelial cells suggests an additional role for endothelial-to-mesenchymal transition in tumor progression. Int J Cancer 2011; 128(6): 1502-3.
37. van Meeteren LA, ten DP. Regulation of endothelial cell plasticity by TGF-beta. Cell Tissue Res 2012; 347(1): 177-86.
38. Anderberg C, Cunha SI, Zhai Z, et al. Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination. J Exp Med 2013; 210(3): 563-79.
39. Gasperini P, Espigol-Frigole G, McCormick PJ, et al. Kaposi Sarcoma Herpesvirus Promotes Endothelial-to-Mesenchymal Transition throughNotch-Dependent Signaling. Cancer Res 2012; 72(5): 1157-69.
40. Cheng F, Pekkonen P, Laurinavicius S, et al. KSHV-initiated notch activation leads to membrane-type-1 matrixmetalloproteinase dependent lymphatic endothelial-to-mesenchymal transition. Cell Host Microbe 2011; 10(6): 577-90.
41. Thapar A, Jenkins IH, Mehta A, Davies AH. Diagnosis and management of carotid atherosclerosis. BMJ 2013; 346: f1485.
42. Arciniegas E, Sutton AB, Allen TD, Schor AM. Transforming growth factor beta 1 promotes the differentiation of endothelial cells into smooth muscle-like cells in vitro. J Cell Sci 1992; 103 (Pt 2): 521-9.
43. Lounev VY, Ramachandran R, Wosczyna MN, et al. Identification of progenitor cells that contribute to heterotopic skeletogenesis. J Bone Joint Surg Am 2009; 91(3): 652-63.
44. Stawski L, Han R, Bujor AM, Trojanowska M. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther 2012; 14(4): R194.
45. Chrobak I, Lenna S, Stawski L, Trojanowska M. Interferon-gamma promotes vascular remodeling in human microvascular endothelial cells by upregulating endothelin (ET)-1 and transforming growth factor (TGF) beta2.LID-10.1002/jcp.24337 [doi]. J Cell Physiol 2013.
46. Del PN, Quirici N, Soligo D, et al. Bone marrow endothelial progenitors are defective in systemic sclerosis. Arthritis Rheum 2006; 54(8): 2605-15.
47. Tang R, Li Q, Lv L, et al. Angiotensin II mediates the highglucose-induced endothelial-to-mesenchymaltransition in human aortic endothelial cells. Cardiovasc Diabetol 2010; 9: 31.
48. Aisagbonhi O, Rai M, Ryzhov S, Atria N, Feoktistov I, Hatzopoulos AK. Experimental myocardial infarction triggers canonical Wnt signaling andendothelial-to-mesenchymal transition. Dis Model Mech 2011; 4(4): 469-83.
49. Patel T, Charytan DM. Cardiovascular complications in diabetic kidney disease. Semin Dial 2010; 23(2): 169-77.
50. Tang R, Gao M, Wu M, Liu H, Zhang X, Liu B. High glucose mediates endothelial-to-chondrocyte transition in human aortic endothelial cells. Cardiovasc Diabetol 2012; 11: 113.
51. Jester JV, Petroll WM, Barry PA, Cavanagh HD. Expression of alpha-smooth muscle (alpha-SM) actin during corneal stromal wound healing. Invest Ophthalmol Vis Sci 1995; 36(5): 809-19.
52. Garana RM, Petroll WM, Chen WT, et al. Radial keratotomy. II. Role of the myofibroblast in corneal wound contraction. Invest Ophthalmol Vis Sci 1992; 33(12): 3271-82.
53. Reneker LW, Bloch A, Xie L, Overbeek PA, Ash JD. Induction of corneal myofibroblasts by lens-derived transforming growth factor beta1 (TGFbeta1): a transgenic mouse model. Brain Res Bull 2010; 81(2-3): 287-96.
54. Zhu P, Huang L, Ge X, Yan F, Wu R, Ao Q. Transdifferentiation of pulmonary arteriolar endothelial cells into smooth muscle-like cells regulated by myocardin involved in hypoxia-induced pulmonary vascular remodelling. Int J Exp Pathol 2006; 87(6): 463-74.
55. Long L, Crosby A, Yang X, et al. Altered bone morphogenetic protein and transforming growth factor-beta signaling in rat models of pulmonary hypertension: potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease. Circulation 2009; 119(4): 566-76.
56. Reynolds AM, Holmes MD, Danilov SM, Reynolds PN. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension. Eur Respir J 2012; 39(2): 329-43.
57. Tang RN, Lv LL, Zhang JD, et al. Effects of angiotensin II receptor blocker on myocardialendothelial-to-mesenchymal transition in diabetic rats. Int J Cardiol 2013; 162(2): 92-9.
58. Widyantoro B, Emoto N, Nakayama K, et al. Endothelial cell derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition. Circulation 2010; 121(22): 2407-18.
59. Segel MJ, Izbicki G, Cohen PY, et al. Role of interferon-gamma in the evolution of murine bleomycin lung fibrosis. Am J Physiol Lung Cell Mol Physiol 2003; 285(6): L1255-62.
60. Wastowski IJ, Sampaio-Barros PD, Martelli-Palomino G, et al. Association of Interferon-gamma gene polymorphism (+874 T/A) with systemic sclerosis. Dis Markers 2009; 27(2): 93-5.
61. Chen PY, Qin L, Barnes C, et al. FGF regulates TGF-beta signaling and endothelial-to-mesenchymal transition via control of let-7 miRNA expression. Cell Rep 2012; 2(6): 1684-96.
62. Maleszewska M, Moonen JR, Huijkman N, van de Sluis B, Krenning G, Harmsen MC. IL-1beta and TGFbeta2 synergistically induce endothelial to mesenchymal transition in an NFkappaB dependent manner. Immunobiology 2012.
63. Mahler GJ, Farrar EJ, Butcher JT. Inflammatory cytokines promote mesenchymal transformation in embryonic and adult valve endothelial cells. Arterioscler Thromb Vasc Biol 2013; 33(1): 121-30.
64. Boerma M, Hauer-Jensen M. Potential targets for intervention in radiation-induced heart disease. Curr Drug Targets 2010; 11(11): 1405-12.
65. Wang J, Boerma M, Fu Q, Hauer-Jensen M. Significance of endothelial dysfunction in the pathogenesis of early and delayed radiation enteropathy. World J Gastroenterol 2007; 13(22): 3047-55.
66. Horwitz EM. Building bone from blood vessels. Nat Med 2010; 16(12): 1373-4.
67. Gao H, Zhang J, Liu T, Shi W. Rapamycin prevents endothelial cell migration by inhibiting the endothelial-to-mesenchymal transition and matrix metalloproteinase-2 and-9: an in vitro study. Mol Vis. 2011; 17: 3406-14.
68. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial mesenchymal transitions in development and disease. Cell 2009; 139(5): 871-90.
69. Voyta JC, Via DP, Butterfield CE, Zetter BR. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 1984; 99(6): 2034-40.
70. Frid MG, Kale VA, Stenmark KR. Mature vascular endothelium can give rise to smooth muscle cells via endothelial-mesenchymal transdifferentiation: in vitro analysis. Circ Res 2002; 90(11): 1189-96.
71. Shoshani O, Zipori D. Transition of endothelium to cartilage and bone. Cell Stem Cell 2011; 8(1): 10-1.
72. Dudley AC, Khan ZA, Shih SC, et al. Calcification of multipotent prostate tumor endothelium. Cancer Cell 2008; 14(3): 201-11.
73. Rampichova M, Chvojka J, Buzgo M, et al. Elastic three dimensional poly (epsilon-caprolactone) nanofibre scaffold enhances migration, proliferation and osteogenic differentiation of mesenchymal stem cells. Cell Prolif 2013; 46(1): 23-37.
74. Xiao Y, Mareddy S, Crawford R. Clonal characterization of bone marrow derived stem cells and their application for bone regeneration. Int J Oral Sci 2010; 2(3): 127-35.
75. Jing W, Wu L, Lin Y, Liu L, Tang W, Tian W. Odontogenic differentiation of adipose-derived stem cells for tooth regeneration: necessity, possibility, and strategy. Med Hypotheses 2008; 70(3): 540-2.
76. Susienka MJ, Medici D. Vascular endothelium as a novel source of stem cells for bioengineering. Biomatter 2013; 3(3). Pii: e24647. [Epub ahead of print]
77. Normand J, Karasek MA. A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin. In vitro Cell Dev Biol Anim 1995; 31(6): 447-55.
78. Asahara T, Murohara T, Sullivan A, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science (New York, N.Y.) 1997; 275(5302): 964-7.
79. Boyer M, Townsend LE, Vogel LM, et al. Isolation of endothelial cells and their progenitor cells from human peripheral blood. J Vasc Surg 2000; 31(1 Pt 1): 181-9.
80. Lewinson D, Maor G, Rozen N, Rabinovich I, Stahl S, Rachmiel A. Expression of vascular antigens by bone cells during bone regeneration in a membranous bone distraction system. Histochem Cell Biol 2001; 116(5): 381-8.